高级检索
当前位置: 首页 > 详情页

The Bidirectional Regulation between MYL5 and HIF-1 alpha Promotes Cervical Carcinoma Metastasis

文献详情

资源类型:
机构: [1]Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China [2]The First Affiliated Hospital of Sun Yat-sen University Guangzhou 510080, People’s Republic of China [3]The Second Affiliated Hospital, Nanchang University, Nanchang 330000, P. R. China
出处:
ISSN:

关键词: MYL5 cervical cancer oxygen regulation

摘要:
Myosin light chains (MLC) serve important regulatory functions in a wide range of cellular and physiological processes. Recent research found that MLC are also chromatin-associated nuclear proteins which regulate gene transcription. In this study, the MLC member myosin regulatory light chain 5 (MYL5) expression was upregulated in late stage cervical cancer patients, positively correlated with pelvic lymph node metastasis, and identified as a poor survival indicator. MYL5 overexpression promoted metastasis in cervical cancer in vitro and in vivo models, whereas MYL5 silencing had the converse effect. We demonstrated a bidirectional regulation between MYL5 and hypoxia inducible factor-1 alpha (HIF-1 alpha). HIF-1 alpha activates MYL5 via binding to the hypoxia response element (HRE) in the promoter of MYL5, and MYL5 could sustain HIF-1 alpha expression by tethering to recognition sequence AGCTCC in the HIF-1 alpha promoter region. Clinical data confirmed a positive correlation between MYL5 and HIF-1 alpha. In summary, our data show that MYL5 may act as a prognosis predictive factor in cervical carcinoma, and strategies that inhibit the interaction of MYL5 and HIF-1 alpha may benefit the cervical carcinoma patients with metastasis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
第一作者:
第一作者机构: [1]Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
共同第一作者:
通讯作者:
通讯机构: [1]Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China [*1]651 Dongfeng Road East, Guangzhou, Guangdong 510060, P. R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43378 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号